The FDA has ordered manufacturers of drugs containing GLP-1 receptor agonists to include warnings about the risk of developing anterior ischemic optic neuropathy, a condition that can lead to vision loss, although experts maintain that the benefits of these drugs continue to outweigh the potential risks. #FDA #semaglutida #obesidad (translated)














